Back to search

Democritus University of Thrace (DUTH)

Συσχετίσεις ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου με διαφορετικές εκδηλώσεις από το νευρικό σύστημα

Abstract

dc:description

SUMMARYInflammatory bowel disease (IBD) comprises a group of chronic, relapsing, inflammatory conditions of the gastrointestinal tract, with Crohn’s disease and ulcerative colitis (UC) being the major types. They are associated with various extraintestinal manifestations (most commonly musculoskeletal, dermatologic, and ocular) in a percentage that probably reaches 36%. Neurologic involvement in inflammatory bowel disease (IBD) is rare though probably underreported. One of the most common neurological conditions described in both Crohn’s disease and ulcerative colitis (UC) is peripheral neuropathy. Its incidence is variable and ranges between 0%-39%. Types of PN described in IBD patients include small and large fiber PN, acute and chronic, axonal and demyelinating, autonomic neuropathy, and bibrachial plexopathy.The aim of this study was to examine possible PN electrophysiologically in IBD patients without neurological clinical symptoms and signs (and without comorbidities associated with PN) to detect early abnormalities and discuss whether proper electrophysiological testing is required as screening in asymptomatic patients.A total of 97 patients with inflammatory bowel disease, established by clinical, endoscopic, pathological and radiological criteria, were prospectively assessed and included in the study. Only patients with IBD diagnosed since at least 1 year were included. Patients with comorbidities associated with PN (diabetes, vitamindeficiency, such as B12 or folate, history of prolonged metronidazole exposure, history of thyroid disease), patients with vascular risk factors, older than 75 years of age and those with known neurological complications or overt clinical neurological symptoms or signs were excluded.Of the 97 patients examined, 45 were eligible for the study, on the basis of the inclusion criteria. The remaining patients were subjected to electrophysiological testing which included motor nerve conduction studies, including F-waves for the median, ulnar, peroneal and tibial nerves, and sensory nerve conduction studies for the median, ulnar, and sural nerves unilaterally.Of the 52 patients who were excluded, 13 patients had diabetes, 11 had low B12 (<200 pg/ml), four had a history of hypothyroidism, and 19 had hypertension and/or hyperlipidemia.Five patients had a known history of neurological disease or they presented neurological symptoms and signs during their visit: two patients had multiple sclerosis, one had an astrocytoma, one had a history of acute myelitis, and another had a history of acute polyneuropathy . None of the patients had been treated with metronidazole for more than 10 days.After excluding the above-mentioned categories, 45 patients (17 women and 28 men, mean age 42 years, range 17–71 years) remained. Sixty-seven percent had Crohn’s disease and 33% had UC. Disease activity was variable, with a mean CDI value of 130 (range 26–458) and a mean SCCAI value of 5 (range 0–11). Current pharmacological regimens for IBD comprised 5-ASA in 65%, corticosteroids in 41%, TNF-a inhibitors in 57%, and other immunosuppressants (azathioprine, 6-mercaptopurine,methotrexate) in 45%.Neurological examination (cranial nerves evaluation, motor and sensory testing, deep tendon and plantar reflexes) indicated no abnormalities. Nerve conduction studies were within normal limits in all patients examined, except for one patient with mild incidental carpal tunnel syndrome.In conclusion, based on the results of the study, we can assume that IBD patients with no neurological complaints and a normal clinical neurological examination had normal nerve conduction studies. Although the incidence of neuropathy is higher in IBD than in the normal population, as reported in many studies, there is no proof of the necessity or the value of routine neurophysiological testing in asymptomatic patients, particularly if clinical examination is normal.Further electrophysiological testing should be reserved for symptomatic patients or patients with clinical signs, in an effort to optimize the standard care of IBD patients, offering all the necessary diagnostic and treatment procedures and limiting unnecessary procedures. Proper electrophysiological testing is invaluable in the diagnosis and differentiation of PN, but it involves expertise, is time-consuming and expensive, and may cause distress to the patient. Therefore, its use should be limited where indications are present, as a supplement to the clinical examination. Larger studies may be needed to reveal the neurophysiological testing as a follow-up method to determine whether peripheral neuropathy develops at a later stage or nerve conduction studies values reduce at a higher rate than expected.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bampali, Asimenia
  • Μπαμπαλή, Ασημένια

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35150

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bampali, Asimenia; Μπαμπαλή, Ασημένια. Συσχετίσεις ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου με διαφορετικές εκδηλώσεις από το νευρικό σύστημα. Democritus University of Thrace (DUTH), 2014. http://hdl.handle.net/10442/hedi/35150